Elekta (OTCMKTS:EKTAY) Shares Gap Up – Time to Buy?

Elekta AB (OTCMKTS:EKTAY) gapped up prior to trading on Thursday . The stock had previously closed at $5.75, but opened at $6.00. Elekta shares last traded at $6.00, with a volume of 226 shares changing hands.

Analyst Upgrades and Downgrades

EKTAY has been the topic of several recent analyst reports. Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 16th. UBS Group started coverage on Elekta in a research report on Wednesday, September 3rd. They set a “sell” rating on the stock. Three research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Elekta currently has a consensus rating of “Reduce”.

Elekta Trading Up 4.5%

The business’s fifty day moving average price is $5.11 and its 200 day moving average price is $5.06. The company has a quick ratio of 0.82, a current ratio of 1.05 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $2.21 billion, a PE ratio of 85.73 and a beta of 1.04.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings data on Wednesday, November 26th. The company reported $0.07 earnings per share (EPS) for the quarter. Elekta had a net margin of 1.62% and a return on equity of 12.06%. The company had revenue of $427.85 million during the quarter, compared to analysts’ expectations of $436.91 million. As a group, analysts expect that Elekta AB will post 0.36 EPS for the current fiscal year.

Elekta Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.